Form 4: Encompass Health EVP Douglas Coltharp Reports Stock Award and Dispositions

Encompass Health's EVP & Chief Financial Officer, Douglas Coltharp, reports acquisition of restricted stock and dispositions, along with holdings in irrevocable trusts and spousal ownership.

Summary

• Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, filed a Form 4 on February 21, 2025.
• The report details changes in beneficial ownership of Encompass Health common stock.
• On February 20, 2025, Coltharp acquired 4,557 shares of Encompass Health common stock as an annual award of restricted stock under the company's 2016 Omnibus Performance Incentive Plan at $0.
• Coltharp also disposed of an unspecified amount of Encompass Health Common Stock.
• Following the reported transactions, Coltharp directly owns 63,117 shares.
• He also indirectly owns 125,631 shares through an irrevocable trust for the benefit of his children and 65,229 shares held by his spouse, but disclaims beneficial ownership of the spousal holdings.

Sentiment

Score: 5

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of restricted stock is mildly positive, while the disposition is mildly negative, balancing out overall.

Positives

• The acquisition of restricted stock suggests confidence in the company's future performance, as these awards are typically tied to performance metrics.

Negatives

• The document mentions the disposition of an unspecified amount of Encompass Health Common Stock, which could be interpreted negatively.

Risks

• The Form 4 filing itself doesn't inherently indicate risks, but changes in ownership could reflect personal financial decisions or concerns about the company's prospects.

Future Outlook

The document does not contain any explicit forward-looking statements or guidance.

Management Comments

• The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Monitoring these filings can offer insights into management's perspective on the company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It may influence investor sentiment depending on the interpretation of the stock acquisition and disposition.

Key Dates

Keywords

Form 4, Encompass Health, Coltharp, Beneficial Ownership, Restricted Stock, EHC, Officer, Acquisition, Disposition